Professional
Added to YB: 2026-07-07
Pitch date: 2026-04-30
AZN [bullish]
AstraZeneca PLC
-7.4%
current return
Author Info
No bio for this author
Company Info
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Market Cap
GBP 243.7B
Pitch Price
GBP 137.13
Price Target
N/A
Dividend
2.01%
EV/EBITDA
13.14
P/E
23.52
EV/Sales
4.42
Sector
Pharmaceuticals
Category
growth
Bell Global Equities Fund New Position: AstraZeneca PLC
AZN (new position): Global biopharma w/ diversified high-quality pipeline across oncology, rare diseases, biopharma—reduces single-asset reliance, offers optionality. Strong R&D/commercialization execution, manageable patent exposure, visible earnings/cash flow. Pullback on camizestrant negative FDA advisory vote seen as immaterial given pipeline depth. High-quality compounder at attractive valuation.
Read full article (1 min)